HyperCard 10 mg Coated Tablets for Cats
HyperCard 10 mg Coated Tablets for Cats
Suspended
- Diltiazem hydrochloride
Product identification
Medicine name:
HyperCard 10 mg Coated Tablets for Cats
HYPERCARD
Active substance:
- Diltiazem hydrochloride
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Diltiazem hydrochloride10.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC08DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Suspended
Authorised in:
-
France
Package description:
- Tablets are located in a preformed low density polyethylene base containing 10 tablets and sealed with PC 100 laminate comprising of low density polyethylene and aluminium foil. Once sealed, 3 blisters of 10 tablets (30 tablets) are placed in a cardboard box.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Dales Pharmaceuticals Limited
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/8810679 1/2004
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0506/001
Concerned member states:
-
France
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
French (PDF)
Published on: 4/04/2022
How useful was this page?:
